ResMed
314 hedge funds and large institutions have $3.93B invested in ResMed in 2015 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 132 increasing their positions, 94 reducing their positions, and 32 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 132 | Existing positions reduced: 94
13% more call options, than puts
Call options by funds: $20.6M | Put options by funds: $18.2M
2.09% more ownership
Funds ownership: 53% → 55.08% (+2.1%)
6% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 32
0% more funds holding
Funds holding: 313 → 314 (+1)
7% less capital invested
Capital invested by funds: $4.21B → $3.93B (-$275M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$73.3M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$52M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$41.2M |
| 4 |
T
TOBAM
Paris,
France
|
+$22.8M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$18.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$58.2M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$32.8M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$27.6M |
| 4 |
APG Asset Management
Amsterdam,
Netherlands
|
-$15.9M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$15.7M |
RMD Hedge Fund Activity: Q3 2015 in Review
314 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q3 2015, worth a combined $3.93B — down 6.5% from $4.21B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new RMD positions and 32 closed out — a net gain of 2 holders — while 132 added to existing stakes and 94 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $73.3M. The largest seller was First Trust Advisors, cutting an estimated $58.2M.
- 314 institutional investors held ResMed (RMD) as of Q3 2015, up from 313 in Q2 2015.
- Funds reported $3.93B of ResMed stock for Q3 2015, down 6.5% quarter-over-quarter.
- 34 funds opened new ResMed positions in Q3 2015 and 32 closed out, a net change of +2 holders.
- The largest ResMed buyer in Q3 2015 was Renaissance Technologies, an estimated $73.3M added.
- The largest ResMed seller in Q3 2015 was First Trust Advisors, an estimated $58.2M sold.
Based on aggregated 13F filings for Q3 2015.